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Abstract Hereditary fructose intolerance (HFI) is a recessively
inherited disorder of carbohydrate metabolism caused by im-
paired function of human liver aldolase (B isoform). 25 en-
zyme-impairing mutations have been identi¢ed in the aldolase
B gene. We have studied the HFI-related mutant recombinant
proteins W147R, A149P, A174D, L256P, N334K and v6ex6 in
relation to aldolase B function and structure using kinetic assays
and molecular graphics analysis. We found that these mutations
a¡ect aldolase B function by decreasing substrate a⁄nity, max-
imal velocity and/or enzyme stability. Finally, the functional and
structural analyses of the non-natural mutant Q354E provide
insight into the catalytic role of Arg303, whose natural mutants
are associated to HFI.
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1. Introduction
Aldolase B, the hepatic isozyme of fructose-1,6-aldolase
(EC 4.1.2.13), catalyzes the speci¢c and reversible cleavage
of fructose-1,6-bisphosphate (FBP) and fructose-1-phosphate
(F1P) into dihydroxyacetone phosphate and D-glyceralde-
hyde-3-phosphate, or D-glyceraldehyde, respectively. Aldolase
B is equally active with FBP and F1P, whereas aldolase A and
aldolase C, the other two vertebrate isozymes, are more active
with FBP than with F1P [1]. In humans, aldolase B de¢ciency
causes hereditary fructose intolerance (HFI; OMIM 229600),
a recessively inherited disorder of carbohydrate metabolism
whose frequency is estimated at 1 in 20 000 live births [2].
The human aldolase B gene is 14 500 bp long; it consists of
nine exons and encodes a 364 amino acid polypeptide (type B
monomer). The functional enzyme is a homotetramer of
about 160 kDa [1]. Missense and nonsense mutations, large
and small deletions and mutations in the splicing region have
been identi¢ed in the aldolase B gene of HFI patients [3^6].
The e¡ects of missense mutations R134C [7], R303Q and
R303W [8], and A337V [9] on aldolase B function have pre-
viously been investigated by in vitro expression and character-
ization of the recombinant enzymes [7^9]. Here we have ex-
pressed and characterized the natural mutants W147R,
A149P, A174D, L256P, N334K and v6ex6 in an attempt to
evaluate the e¡ect of structural perturbations on the three-
dimensional structure and on the consequent functional activ-
ity of the enzyme. Crystallographic studies on rabbit aldolase
A showed that Arg303 and Glu354 side chains form a strong
salt bridge, which may be important in the release of the
enzyme product [10]. Consequently, we investigated the role
played by Arg303 in aldolase B enzymatic activity by charac-
terizing the Q354E mutant. We then analyzed the structural
perturbations induced by this and the above-mentioned natu-
ral mutations using the recently solved structure of human
aldolase B [11].
2. Materials and methods
2.1. Materials
Restriction endonucleases were purchased from New England Bio-
labs. Taq polymerase, T4 DNA ligase, isopropyl-1-thio-L-D-galacto-
pyranoside, ampicillin, phenylmethanesulfonyl £uoride, and K-glycer-
ol-phosphate dehydrogenase/triose phosphate isomerase (GDH/TIM)
were purchased from Roche Molecular Biochemicals. Imidazole, FBP,
F1P, NADH were purchased from Sigma-Aldrich. The pET-16b vec-
tor and the Escherichia coli strain BL21(DE3) were purchased from
Novagen.
2.2. Construction and expression of mutant aldolase B
The full-length wild type human aldolase B cDNA [12] was cloned
into the His-tag bacterial expression vector pET-16b thereby elongat-
ing the N-terminus of the protein by 10 histidine residues [8,9]. The
pET16b/cDNA construct was used as a template to generate the al-
dolase B missense mutant forms (see Table 1). The QuickChange1
site-directed mutagenesis kit (Stratagene) and speci¢c primers were
used for this procedure. Mutagenesis reactions were carried out with
a Perkin-Elmer 9600 thermal cycler. The parental, methylated DNA
was digested with DpnI, and the newly synthesized DNA was used to
transform the E. coli XL1-blue competent cells, according to the
manufacturer’s instructions. Recombinant mutated plasmids were pu-
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ri¢ed over Qiagen columns (Qiagen, Valencia, CA, USA) and their
full sequence veri¢ed by automated sequencing. Recombinant aldo-
lases B were expressed in the E. coli B strain BL21(DE3). Wild type,
A149P, and Q354E proteins were recovered in soluble form in bac-
teria grown at 37‡C, while W147R, L256P and N334K mutants were
recovered in soluble form at 22‡C, 16 h after induction. Recombinant
proteins corresponding to the A174D and v6ex6 enzymes precipitated
in the E. coli inclusion bodies at both 37‡C and 22‡C. Neither urea
extraction nor guanidine^HCl methods ensured correct refolding of
these latter proteins.
Recombinant enzymes expressed at 37‡C (wild type, A149P, and
Q354E) were puri¢ed on Ni-nitriloacetic resin (Qiagen) as described
elsewhere [8]. Enzymes expressed at 22‡C (W147R, L256P and
N334K) were puri¢ed with the same procedure [8], except that each
of the puri¢cation bu¡ers was supplemented with 20% (v/v) glycerol
to allow enzyme solubilization. Fractions containing the bulk of the
enzyme were pooled, dialyzed against 20 mM Tris^HCl pH 7.5, 50%
(v/v) glycerol and stored at 320‡C. All puri¢cation steps were carried
out at 4‡C. The degree of puri¢cation of each recombinant enzyme
was analyzed by 10% sodium dodecyl sulfate^polyacrylamide gel elec-
trophoresis (SDS^PAGE).
2.3. Molecular mass determination and denaturation pro¢le analysis
Enzyme molecular weights were determined at 25‡C by co-fraction-
ation (fast protein liquid chromatography, FPLC) of the puri¢ed pro-
teins with L-amylase (200 kDa), chicken ovalbumin (44 kDa), and
carbonic anhydrase (29 kDa) on a 50 cmU1.6 cm Sephadex G-200
column (Amersham-Pharmacia Biotech.) in 20 mM Tris^HCl pH 7.4,
20% (v/v) glycerol, with a £ow rate of 0.2 ml/min. By FPLC, we also
separated the tetrameric form of the recombinant enzymes from the
monomeric form, if present (Fig. 1 and Table 2). The thermal stability
of the recombinant enzymes was monitored with an ultraviolet (UV)
melting curve [13] and by measuring the di¡erence of absorbance at
286 and 274 nm versus temperature in the range of 15^75‡C, in 20
mM Tris^HCl pH 7.4, 20% (v/v) glycerol. The same procedure was
used for the previously characterized R303Q and R303W mutants [8].
2.4. Aldolase B activity assays and kinetic studies
The substrate cleavage rate was determined spectrophotometrically
by measuring NADH oxidation at 340 nm in a coupled assay using
GDH/TIM, and FBP or F1P as substrates [9]. Assays were conducted
at 22‡C as described previously [8]. One unit of activity corresponds
to the cleavage of 1 Wmol of hexose substrate/min. For each recombi-
nant enzyme, we ran three assays with at least two di¡erent enzyme
preparations and evaluated the Km and kcat from double reciprocal
plots using a least-square method.
2.5. Molecular graphics analyses
We evaluated mutation-induced structural alterations by compari-
son with the structure of aldolase B recently re¢ned by Littlechild and
co-workers (PDB code 1QO5) [11]. The crystal form used for this
crystallographic study contains 18 independent molecules in the asym-
metric unit. We used the tetramer constituted by subunits A, B, C and
D of the PDB entry in the present analysis, and programs PROMO-
TIF [14], O [15], and PROCHECK [16]. Figs. 2 and 3 were generated
with MOLSCRIPT [17] and Raster3D [18].
3. Results
3.1. Expression and characterization of mutant aldolase B
proteins
The aldolase B mutants studied are listed in Table 1. All the
His-tagged recombinant proteins were puri¢ed to a s 95%
homogeneity by Ni2þ a⁄nity chromatography as veri¢ed by
SDS^PAGE, and each preparation, except N334K expressed
at 37‡C, resulted in a single band (data not shown). The wild
type enzyme and Q354E, expressed at 37‡C, were recovered
from the soluble fraction of the bacterial lysate. After puri¢-
cation, about 10^12 mg of recombinant enzyme per liter of
culture was obtained. A single peak corresponding to 170 kDa
(tetrameric form) was obtained with FPLC. The wild type
Table 1
Positioning of aldolase B missense mutations and corresponding amino acid change within the enzyme protein
Name Exon Nucleotide modi¢cation Amino acid change
R134C [7] 5 TGTCCGT Arg134CCys
W147R [24] 5 TGGCCGG Trp147CArg
A149P [4] 5 GCTCCCT Ala149CPro
A174D [4] 5 GCCCGAC Ala174CAsp
v6ex6 [6] 6 delCTGGTA del Val182^Leu183
L256P [25] 7 CTCCCCC Leu256CPro
R303W [5] 8 CGGCTGG Arg303CTrp
R303Q [8] 8 CGGCCAG Arg303CGln
N334K [26] 9 AACCAAG Asn334CLys
A337V [9] 9 GCGCGTG Ala337CVal
Q354Ea 9 CAGCGAG Gln354CGlu
aNot a naturally occurring HFI mutation.
Fig. 1. FPLC pro¢les of the aldolase B wild type and missense mu-
tants. The arrows indicate the molecular mass corresponding to the
tetrameric (170 kDa) and monomeric form (42.5 kDa), as expected
for the histidine-tagged aldolase B. Molecular masses were derived
by the protein standards used in the calibration (see Section 2).
Each recombinant enzyme is marked by a di¡erent color (see
legend). All puri¢ed aldolase B enzymes (mutants and wild type)
were eluted at 22‡C.
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enzyme and Q354E remained stable at 320‡C in a 50% (v/v)
glycerol solution for at least 1 month.
W147R and L256P were recovered from the soluble frac-
tion of the bacterial lysate only after growth at 22‡C and with
20% (v/v) glycerol. In fact, both mutants completely precipi-
tated in the E. coli inclusion bodies when bacteria grew at
37‡C. Furthermore, the addition of glycerol to the puri¢cation
bu¡er was necessary for enzyme solubilization. The puri¢ca-
tion yield ranged from 2 to 5 mg of recombinant proteins per
liter of culture: most of the enzyme remained in the bacteria
inclusion bodies. In addition to the principal peak corre-
sponding to the tetrameric form of the enzyme, a minor
peak corresponding to the 42.5-kDa monomeric form of al-
dolase B appeared with these two mutants after FPLC (Fig.
1). Fractions containing monomers did not have catalytic ac-
tivity.
Table 2 lists the speci¢c activity of the wild type and the
other mutant enzymes and their thermal stability determined
as Tm. Table 3 shows the kinetic pro¢le of the puri¢ed re-
combinant enzymes. As expected for HFI-causing enzymes,
all the mutant aldolases had reduced catalytic e⁄ciency versus
the substrates.
The kinetics of Q354E resembled that of the wild type en-
zyme except for a slight variation in Km versus both FBP and
F1P; the speci¢c activity ratio and thermal stability were as
the wild type. However, there was a global functional e¡ect
with a fold variance of 4 and 2.6 versus wild type catalytic
e⁄ciency, for FBP and F1P respectively (last two columns in
Table 3).
With the W147R tetramer there was a 3.25- and 2-fold
variance of catalytic e⁄ciency with respect to the wild type,
for FBP and F1P respectively (see Table 3). A similar e¡ect
(fold variance 3.88 and 1.30 for FBP and F1P) was observed
with the L256P mutation. Melting temperature was 40‡C for
enzymes W147R and L256P versus 47‡C for the wild type
(Table 2). Furthermore, these mutants aggregated after 15
days of storage at 320‡C in a 50% glycerol solution, suggest-
ing structural instability.
N334K was recovered from the soluble fraction of the ly-
sate after bacterial growth at 37‡C and 22‡C. SDS^PAGE
analysis of the recombinant enzyme expressed at 37‡C
showed, in addition to the main 40-kDa band, two minor
bands of lower molecular mass that were not observed when
the enzyme was expressed at 22‡C (data not shown). A similar
¢nding has been reported for the V337A recombinant enzyme
[9]. Like the other mutant recombinant enzymes that we ex-
pressed at 22‡C, also the N334K mutant expressed at 22‡C
showed two FPLC peaks corresponding to the tetrameric and
monomeric forms (Fig. 1). Melting temperature was the same
as the wild type. When stored at 320‡C in 50% glycerol,
N334K was stable for about 1 month. There was a fold var-
iance of 37.1 and 8.8 for FBP and F1P respectively (Table 3).
The A149P enzyme was soluble in bacteria grown at 37‡C.
After puri¢cation, FPLC analysis of the A149P aldolase
showed, together with tetrameric and monomeric forms, other
species with molecular masses intermediate between those cor-
responding to the tetramer and monomer. Its Tm of 37.5‡C
was the lowest measured among all other mutated and wild
type proteins. This enzyme did not show any activity for ei-
ther FBP or F1P.
Finally, recombinant aldolase B enzymes corresponding to
A174D and v6ex6 mutants were retained in the E. coli inclu-
sion bodies after growth at 37‡C or 22‡C.
3.2. Molecular graphics analyses
Structurally, the aldolase B missense mutations we have
Table 2
Enzyme activity parameters of various recombinant human aldolase B mutants
Enzyme Speci¢c activity (Wmol min31 mg31) Speci¢c activity
(ratio FBP/F1P)
Tm (‡C)
FBP F1P
Wild type 0.97U 0.05 0.94U0.02 1.032 47.0
W147R 0.64U 0.06 0.38U0.08 1.72 40.0
A149P N.D. N.D. N.D. 37.5
L256P 0.81U 0.04 0.58U0.14 1.3 40.0
N334K 0.28U 0.07 0.13U0.01 1.05 45.0
Q354E 0.86U 0.02 0.88U0.06 1 46.5
R303Wa 0.10U 0.04 N.D. N.D. 46.5
R303Qa 0.47U 0.10 0.25U0.1 2.44 49.0
aData from [8].
Table 3
Kinetic parameters of various recombinant human aldolase B mutants
Enzyme Km kcat (s31) Catalytic e⁄ciency
FBP F1P FBP F1P kcat/Km Decrease in
kcat/Km
FBP F1P FBP F1P
Wild type 2.3U 0.3 WM 2.2U 0.2 mM 0.61U 0.03 0.67U 0.03 0.26U 0.01 0.3U 0.002 ^ ^
W147R 5.5U 0.7 WM 1.70U 0.14 mM 0.43U 0.04 0.25U 0.05 0.077U 0.005 0.16U 0.03 3.25 2
L256P 7.3U 0.6 WM 1.73U 0.25 mM 0.54U 0.03 0.38U 0.09 0.077U 0.004 0.23U 0.04 3.88 1.30
N334K 32.4U 2.0 WM 22.0U 3.0 mM 0.19U 0.05 0.085U 0.005 0.006U 0.001 0.004U 0.001 37.1 8.8
Q354E 9.1U 0.45 WM 5.0U 0.43 mM 0.57U 0.01 0.59U 0.04 0.064U 0.004 0.116U 0.001 4.0 2.6
R303Wa 1.6U 0.6 mM N.D. 0.08U 0.02 N.D. (5.2 U 0.7)U1035 N.D. 4800 N.D.
R303Qa 147U 15 WM 57.5U 11 mM 0.39U 0.04 0.15U 0.02 (2.7 U 0.2)U1033 (2.6U 0.2)U1033 93 119
aData from [8].
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studied fall into three types (Fig. 2A, B). Firstly, Trp147 and
Ala149, together with the previously analyzed Arg303 [8], be-
long to the active site of the enzyme (active site mutations).
Secondly, Ala174 and Leu256 belong to helices involved in tet-
ramer interface (interface mutations); however, these residues
are not directly involved in interactions with residues of other
subunits because their side chains protrude inwards. Thirdly,
Asn334, like the previously characterized Val337 (C-terminal
mutations) [9], is located near the C-terminal region, which
plays an important catalytic role [10]. Interestingly, all these
mutation sites involve residues belonging to secondary struc-
ture elements of aldolase B. Indeed, Trp147 and Ala149 belong
to L-strands, and Ala174, Leu256 and Asn334 belong to K-heli-
ces. This analysis shows that these mutations alter the struc-
tural and the functional integrity of the enzyme by means of a
variety of mechanisms. In particular, enzyme destabilization
may be ascribed to: (a) the introduction of a polar or charged
residue into a hydrophobic environment (W147R and
A174D); (b) the substitution of small with bulkier side chains
(N334R); and (c) the insertion of proline residues in K-helices
or L-strands (L256P and A149P).
4. Discussion
Here we report the biochemical characterization of several
aldolase B mutations related to HFI. In all cases, the catalytic
e⁄ciency of the mutated enzymes was signi¢cantly reduced
compared with the wild type. Bacterial growth at 22‡C is
necessary for the expression and puri¢cation, in soluble
form, of mutants W147R, L256P, and N334K: under these
conditions both tetrameric and inactive monomeric forms
were recovered. W147R and L256P tetramers were partially
active and di¡ered slightly from the wild type in Km and
speci¢c activity towards FBP and F1P (Table 2). Also the
N334K tetramer was partially active, and had a more pro-
nounced e¡ect than W147R and L256P on speci¢c activity
and Km for both substrates. Functional measurements sug-
gested that W147R and L256P have little e¡ect on substrate
binding, but they signi¢cantly reduce catalytic e⁄ciency (Ta-
ble 3). These two mutations probably a¡ect the enzyme fold-
ing process since we were unable to recover them in soluble
form from bacteria grown at physiological temperature. It is
noteworthy that most of the produced enzyme remained in the
E. coli inclusion bodies also after growth at 22‡C.
The fact that we could not recover a soluble form of A174D
and v6ex6 may indicate that the structural perturbations pro-
duced by the mutations a¡ect the overall integrity of the en-
zyme. It is noteworthy that also Cox and co-workers, in an
independent characterization carried out in slightly di¡erent
conditions of some of the mutants (W147R, A149P, A174D,
L256P and N334K), failed to recover the A174D enzyme [19].
Ala174 is located on the apolar side of an amphipatic helix.
Therefore, it is not surprising that the insertion of a charged
and bulkier side chain in this environment a¡ects the overall
structure of the protein.
Fig. 2. Distribution of HFI-related missense mutations in the aldo-
lase B structure. A: The mutation sites are marked as balls only in
the subunit A of the homotetramer. B: Close-up of subunit A struc-
ture. The color code for the mutation sites is: cyan for the active
site, purple for the tetramer interface, green for the C-terminus and
blue for the 134 site. The deletion v6ex6 site is also shown (in yel-
low).
Fig. 3. Intra- and inter-helical interactions of the Asn334 side chain
in the aldolase B structure. The ON1 and NN2 atoms of Asn334 form
hydrogen bonds with Thr280 OQ and Arg330 O atoms, respectively
[13]. For clarity, only the side chains of Asn334 and Thr280 are
shown.
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The alterations induced by the other aldolase B mutations
appear to have a less dramatic e¡ect on the enzyme structure.
As reported by Cox and co-workers [19], W147R, A149P,
L256P and N334K a¡ect the integrity of the tetrameric struc-
ture of aldolase B even though most of them (W147R, A149P
and N334K) are distant from the tetramer interface.
In agreement with Cox and co-workers [19] we found that
all monomeric forms of aldolase B are inactive. Di¡erently,
monomeric aldolase A mutants were reported to retain sig-
ni¢cant activity [20]. Consequently, some functional aspects of
these two enzymes may be strikingly di¡erent despite the high
sequence homology (69%). In contrast with Cox and co-work-
ers [19] we obtained a rather stable mutant N334K. However,
the activity of this mutated enzyme was signi¢cantly reduced.
As suggested by Dalby et al. [11], this may be ascribed to the
structural destabilization of the enzyme caused by the loss of a
hydrogen bond of the Asn334 side chain with the Thr280 side
chain (Fig. 3). It is noteworthy that this interaction is pre-
served in aldolase A, even though in this protein Thr280 is
replaced by a Ser.
Although recovered as a soluble tetramer, we were unable
to detect any activity for the active site mutant A149P after
growth at either 37‡C or 22‡C ^ a ¢nding probably due to the
tendency of this mutant to aggregate rapidly [19]. The high
instability of A149P is supported by the low Tm (Table 2) and
by the FPLC forms with a molecular mass intermediate be-
tween those of tetramer and monomer. Interestingly, the other
active site mutant (W147R) retains a signi¢cant portion of
wild type aldolase B activity. Taken together, these data in-
dicate that the perturbation of enzyme function produced by
the insertion of proline in the L-sheet is greater than that
induced by a dramatic variation of the size and the charge
of the side chain in position 147.
Studies of aldolase A showed that the Arg303 mutation in-
teracts in the various catalytic steps with either the C6 or the
C1 moiety of FBP [21^23]. In addition, Arg303 forms a salt
bridge with Glu354 [10], which is located in the £exible
C-terminal region of aldolase A. This ¢nding suggests that
Arg303 promotes the C-terminus conformation which facili-
tates substrate release. The ¢nding that Glu354 is not con-
served in aldolase B or in other class I aldolases, suggested
that this interaction plays an insigni¢cant role in these en-
zymes [8]. To address this aspect, we characterized the aldo-
lase B mutant Q354E and found that the kcat is practically
una¡ected by the mutation. The small increase in Km may be
ascribed to the extra negative charge of the enzyme. Accord-
ingly, the increase in Km was greater for FBP than for F1P,
which carries a smaller negative charge. These ¢ndings show
that the formation of a salt bridge 303^354, which is believed
to be tucked in the C-terminus in aldolase A, does not sig-
ni¢cantly a¡ect the catalytic properties of aldolase B.
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